Monoclonal Antibody Therapy for COVID-19: A Public Health Perspective From Arkansas

被引：1
|
作者：
Kothari, Atul [1 ,2 ]
Borella, Elizabeth Woodland [1 ]
Smith, Michelle R. [1 ]
机构：
[1] Arkansas Dept Hlth, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Med & Biomed Informat, Little Rock, AR 72205 USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2022年 / 9卷 / 01期
关键词：
COVID; 19; monoclonal antibodies;
D O I：
10.1093/ofid/ofab602
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
COVID-19 monoclonal antibodies revolutionized the treatment for eligible patients who have tested positive for SARS CoV-2 infection in an ambulatory setting. In this short report, we describe our experience assisting in the distribution of monoclonal antibodies in Arkansas during the summer surge of the delta variant.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications
    Loganathan, Subramanian
    Athalye, Sandeep N.
    Joshi, Shashank R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (09) : 1025 - 1031
  • [32] The Relevance of Monoclonal Antibodies in the Treatment of COVID-19
    Torrente-Lopez, Anabel
    Hermosilla, Jesus
    Navas, Natalia
    Cuadros-Rodriguez, Luis
    Cabeza, Jose
    Salmeron-Garcia, Antonio
    VACCINES, 2021, 9 (06)
  • [33] COVID-19 Vaccine Perspective From Adolescents' Lens in the US
    Garg, Meher
    Nagrecha, Arnav A.
    Gupta, Ruchi
    Williams, Makeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [34] Antiviral Therapy of COVID-19
    Gudima, Georgii
    Kofiadi, Ilya
    Shilovskiy, Igor
    Kudlay, Dmitry
    Khaitov, Musa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [35] Impact of COVID-19 monoclonal antibodies on outcomes of COVID-19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients
    Hahn, Elizabeth H.
    Li, Hong
    Sauter, Craig S.
    Mossad, Sherif B.
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (04)
  • [36] COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center
    Vawter, Natalie L. L.
    Godino, Job G. G.
    Lewis, Sydney V. V.
    Northrup, Adam W. W.
    Samaniego, Jane C. C.
    Poblete, Jacqueline Y. Y.
    Guereca, Jesus A. A.
    Sharp, Sydney P. P.
    Matthews, Eva
    Crespo, Noe C. C.
    Lucatero, Pauline G. G.
    Vidaurrazaga, Monica M. M.
    Ramers, Christian B. B.
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [37] COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center
    Natalie L. Vawter
    Job G. Godino
    Sydney V. Lewis
    Adam W. Northrup
    Jane C. Samaniego
    Jacqueline Y. Poblete
    Jesus A. Guereca
    Sydney P. Sharp
    Eva Matthews
    Noe C. Crespo
    Pauline G. Lucatero
    Monica M. Vidaurrazaga
    Christian B. Ramers
    BMC Infectious Diseases, 23
  • [38] Mental Health, Culture and Resilience-Approaching the COVID-19 Pandemic From a South African Perspective
    Mashaphu, Sibongile
    Talatala, Mvuyiso
    Seape, Sebolelo
    Eriksson, Lennart
    Chiliza, Bonginkosi
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [39] Public Health Management of the COVID-19 Pandemic in Australia: The Role of the Morrison Government
    Duckett, Stephen
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (16)
  • [40] Sense of Control and Depression during Public Health Restrictions and the COVID-19 Pandemic
    Msetfi, Rachel
    Kornbrot, Diana
    Halbrook, Yemaya J.
    Senan, Salha
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (21)
12345